High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: Role of hyperosmolarity

Journal of the American Society of Nephrology

Volumn 9, Issue 11, 1998, Pages 2005-2012

  Sitter, Thomas ^a   Haslinger, Bettina ^a   Mandl, Sonja ^a   Fricke, Harald ^a   Held, Eckhard ^a   Sellmayer, Alois ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; CYTOKINE; DIALYSIS FLUID; GLUCOSE; GLUCOSE POLYMER; ICODEXTRIN; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTACYCLIN; PROSTAGLANDIN E2; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA SYNTHESIS; HUMAN; HUMAN CELL; HYPEROSMOLARITY; MESOTHELIUM CELL; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0031728086     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bailie GR, Eisele G: Continuous ambulatory peritoneal dialysis: A review of its mechanics, advantages, complications, and areas of controversy. Ann Pharmacother 26: 1409-1420, 1992
2. Dobbie JW, Pavlina T, Lloyd J, Johnson RC: Phosphatidylcholine synthesis by peritoneal mesothelium: Its implications for peritoneal dialysis. Am J Kidney Dis 12: 31-36, 1988
3. Witowski J, Topley N, Jorres A, Liberek T, Coles GA, Williams JD: Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 47: 282-293, 1995
4. van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J, van Muijen GN: Characterization and fibrinolytic properties of human omental tissue mesothelial cells: Comparison with endothelial cells. Blood 75: 1490-1497, 1990
5. Sitter T, Toet K, Fricke H, Schiffl H, Held E, Kooistra T: Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 271: R1256-R1263, 1996
6. Coene MC, Van Hove C, Claeys M, Herman AG: Arachidonic acid metabolism by cultured mesothelial cells: Different transformations of exogenously added and endogenously. Biochim Biophys Acta 710: 437-445, 1982
7. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37: 1563-1570, 1990
8. Topley N, Petersen MM, Mackenzie R, Neubauer A, Stylianou E, Kaever V, Davies M, Coles GA, Jorres A, Williams JD: Human peritoneal mesothelial cell prostaglandin synthesis: Induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 46: 900-909, 1994
9. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P, Bernini M, Pucci AM, Ibba L, Sabatelli P: Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 44: 204-211, 1986
10. Slingeneyer A, Canaud B, Mion C: Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: An epidemiological study. Nephron 33: 133-138, 1993
11. Steinhauer HB, Schollmeyer P: Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. Kidney Int 29: 584-590, 1986
12. Steinhauer HB, Gunter B, Schollmeyer P: Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Invest 15: 1-5, 1985
13. Zemel DM, Koomen GC, Hart AAM, ten Berge IJ, Struijk DG, Krediet RK: Relationship of TNF-α, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 6: 686-696, 1993
14. Knudsen PJ, Dinarello CA, Strom TB: Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 137: 3189-3194, 1986
15. Jörres A, Topley N, Gahl GM: Biocompatibility of peritoneal dialysis fluids [Editorial]. Int J Artif Organs 15: 79-83, 1992
16. Breborowicz A, Rodela H, Oreopoulos DG: Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 41: 1280-1285, 1992
17. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE: Potent selective inhibitors of protein kinase C. FEBS Lett 259: 61-63, 1989
18. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995
19. Mistry CD, Gokal R: The use of glucose polymer (icodextrin) in peritoneal dialysis: An overview. Perit Dial Int 14: S158-S161, 1994
20. Sellmayer A, Uedelhoven WM, Weber PC, Bonventre JV: Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells. J Biol Chem 266: 3800-3807, 1991
21. Keller HU, Niggli V: The PKC-inhibitor Ro 31-8220 selectively suppresses PMA- and diacylglycerol-induced fluid pinocytosis and actin polymerization in PMNs. Biochem Biophys Res Commun 194: 1111-1116, 1993.
22. Campbell JS, Seger R, Graves JD, Graves LM, Jensen AM, Krebs EG: The MAP kinase cascade. Recent Prog Horm Res 50: 131-159, 1995
23. Satoh K, Prescott SM: Culture of mesothelial cells from bovine pericardium and characterization of their arachidonate metabolism. Biochim Biophys Acta 930: 283-296, 1987
24. Hott JW, Godbey SW, Antony VB: Mesothelial cell modulation of pleural repair: Thrombin stimulated mesothelial cells release prostaglandin E2. Prostaglandins Leukotrienes Essent Fatty Acids 51: 329-335, 1994
25. Williams B, Schrier RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92: 2889-2896, 1993
26. Choi K: Effect of high glucose concentration on phospholipase A2 activity in mesangial cells. Kidney Int Suppl 51: S22-S27, 1995
27. Petronini PG, Tramacere M, Mazzini A, Piedimonte G, Silvotti L, Borghetti AF: Hyperosmolarity-induced stress proteins in chick embryo fibroblasts. Exp Cell Res 172: 450-462, 1987
28. Itoh T, Yamauchi A, Miyai A, Yokoyama K, Kamada T, Ueda N, Fujiwara Y: Mitogen-activated protein kinase and its activator are regulated by hypertonic stress in Madin-Darby canine kidney cells. J Clin Invest 93: 2387-2392, 1994
29. Zhang F, Warskulat U, Wettstein M, Schreiber R, Henninger HP, Decker K, Haussinger D: Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages. Biochem J 312: 135-143, 1995
30. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D: Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267: 25934-25938, 1992
31. Yamamoto K, Arakawa T, Ueda N, Yamamoto S: Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270: 31315-31320, 1995
32. Flower RJ, Blackwell GJ: The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem Pharmacol 25: 285-291, 1976
33. Parker J, Daniel LW, Waite M: Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis. J Biol Chem 262: 5385-5393, 1987
34. Craven PA, Patterson MC, De Rubertis FR: Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 37: 429-435, 1988
35. Haneda M, Kikkawa R, Sugimoto T, Koya D, Araki S, Togawa M, Shigeta Y: Abnormalities in protein kinase C and MAP kinase cascade in mesangial cells cultured under high glucose conditions. J Diabetes Complications 9: 246-248, 1995
36. Cohen P: The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 7: 353-361, 1997
37. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46: 847-853, 1997
38. Matsuda S, Kawasaki H, Moriguchi T, Gotoh Y, Nishida E: Activation of protein kinase cascades by osmotic shock. J Biol Chem 270: 12781-12786, 1995
39. Davenport KR, Sohaskey M, Kamada Y, Levin DE, Gustin MC: A second osmosensing signal transduction pathway in yeast: Hypotonic shock activates the PKC1 protein kinase-regulated cell integrity pathway. J Biol Chem 270: 30157-30161, 1995